Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/19466315.2014.1003090 http://scihub22266oqcxt.onion/10.1080/19466315.2014.1003090 C4382106!4382106!25844122     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Stat+Biopharm+Res 2015 ; 7 (1): 36-54 Nephropedia Template TP {{tp|p=25844122|t=2015. Group-Sequential Strategies in Clinical Trials with Multiple Co-Primary Outcomes |pdf=|usr=}}{{25844122}} gab.com Text Group-Sequential Strategies in Clinical Trials with Multiple Co-Primary Outcomes JO: Stat Biopharm Res http://www.kidney.de/pget.php?&tw=1&pmid=25844122 #FOAvip We discuss the decision-making frameworks for clinical trials with multiple co-primary endpoints in a group-sequential setting. The decision-making frameworks can account for flexibilities such as a varying number of analyses, equally or unequally spaced increments of information and fixed or adaptive Type I error allocation among endpoints. The frameworks can provide efficiency, i.e., potentially fewer trial participants, than the fixed sample size designs. We investigate the operating characteristics of the decision-making frameworks and provide guidance on constructing efficient group-sequential strategies in clinical trials with multiple co-primary endpoints. Twit Text FOAVip Group-Sequential Strategies in Clinical Trials with Multiple Co-Primary Outcomes ????Stat Biopharm Res http://www.kidney.de/pget.php?&tw=1&pmid=25844122 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25844122 #FOAvip English Wikipedia <ref>{{Cite pmid|25844122}}</ref> Group-Sequential Strategies in Clinical Trials with Multiple Co-Primary Outcomes #MMPMID25844122 Hamasaki T; Asakura K; Evans SR; Sugimoto T; Sozu T Stat Biopharm Res 2015[]; 7 (1): 36-54 PMID25844122show ga We discuss the decision-making frameworks for clinical trials with multiple co-primary endpoints in a group-sequential setting. The decision-making frameworks can account for flexibilities such as a varying number of analyses, equally or unequally spaced increments of information and fixed or adaptive Type I error allocation among endpoints. The frameworks can provide efficiency, i.e., potentially fewer trial participants, than the fixed sample size designs. We investigate the operating characteristics of the decision-making frameworks and provide guidance on constructing efficient group-sequential strategies in clinical trials with multiple co-primary endpoints. äGroup-Sequential Strategies in Clinical Trials with Multiple Co-Primar(epmc).pdf DeepDyve Pubget Overpricing